IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Serum Folic Acid Levels in Preterm Infants (FALIPI)
This study has been completed.
Sponsor:
Mehmet Yekta
Information provided by (Responsible Party):
Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital
ClinicalTrials.gov Identifier:
NCT01360528
First received: May 23, 2011
Last updated: February 15, 2012
Last verified: February 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Therefore preterm infants must need folic acid replacement than term babies.
| Condition |
|---|
| Very Low Birth Weight Baby |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Zekai Tahir Burak Maternity and Teaching Hospital |
Resource links provided by NLM:
Further study details as provided by Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital:
| Enrollment: | 100 |
| Study Start Date: | February 2011 |
| Study Completion Date: | October 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Extremely low birth weight
Extremely low birth weight under 1000 gram
|
|
Very low birth weight
Between 1000-1500 gram babies
|
|
Low birth weight
Between 1500-2500 gram
|
Detailed Description:
All babies need to different vitamin supplementation. Especially preterm infants need some vitamin supplements. Folic acid is very important structure of part of cell growing.ın theorically; preterm infants have very rapid cell reproduction capacity than term infants. Therefore preterm infants must need folic acid replacement than term babies. The investigators want to determine preterm infants folic acid levels due to gestational age whether needs folic acid replacement.
Eligibility| Ages Eligible for Study: | 24 Weeks to 34 Weeks (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Extremely low birth weight, Very low birth weight, Low birth weight
Criteria
Inclusion Criteria:
-All preterm infants
Exclusion Criteria:
-Major congenital anomaly
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01360528
Please refer to this study by its ClinicalTrials.gov identifier: NCT01360528
Locations
| Turkey | |
| Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit | |
| Ankara, Turkey, 06600 | |
Sponsors and Collaborators
Mehmet Yekta
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital |
| ClinicalTrials.gov Identifier: | NCT01360528 History of Changes |
| Other Study ID Numbers: |
ztb5326315185 |
| Study First Received: | May 23, 2011 |
| Last Updated: | February 15, 2012 |
Keywords provided by Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital:
|
Folic acid replacement Folic acid Preterm neonate |
Additional relevant MeSH terms:
|
Birth Weight Body Weight Signs and Symptoms Folic Acid Vitamin B Complex |
Hematinics Vitamins Micronutrients Growth Substances Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on June 23, 2017